title: [Target-oriented tumor therapy -- proof of the principle].
authors.forename: G
authors.initials: G
authors.lastname: Gastl
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides; D016503:Drug Delivery Systems / Q000592:standards*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D010879:Piperazines / Q000008:administration & dosage; D011743:Pyrimidines / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate
vernacular_title: Target-orientierte Tumortherapie -- das Prinzip funktioniert.